Dechert LLP

Intellectual Property

Partner

Amanda K. Antons, Ph.D.’s practice focuses on patent litigation, specifically in the pharmaceutical and biotechnology industries, including biologics litigation, Abbreviated New Drug Application litigation, Patent Trial and Appeal Board proceedings, European Patent Office proceedings, other contentious patent office matters including interferences, and related trade secrets litigation. Her doctoral training, including work on T cell/HIV interactions, provides her with significant research experience and knowledge in the biotechnology and life sciences industries. Her cases have dealt with a wide variety of technologies, including monoclonal antibodies (e.g., ixekizumab, adalimumab, anti-PD-1/L1 antibodies), and other biologics (e.g., AAV viral vectors, aflibercept, CRISPR, epopoietin), peptides (e.g., insulin glargine, daptomycin), DNA sequencing and small-molecule therapeutics.